115.02 USD
↗ 5.16 (4.70%)AT CLOSE (03:59 PM EST)
Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is currently trading at $115.02. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 13, 2026.